Search

Author/Creator Stegert, Mario

1. Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Issue 12 (December 2021)

Authors:
Fischer, Matthias; Moreno, Lucas; Ziegler, David S; Marshall, Lynley V; Zwaan, C Michel; Irwin, Meredith S; Casanova, Michela; Sabado, Constantino; Wulff, Beate; Stegert, Mario; Wang, Luojun; Hurtado, Felipe K; Branle, Fabrice; Geoerger, Birgit; Schulte, Johannes H
Journal:
Lancet oncology
Issue:
Volume 22:Issue 12(2021)
Page Start:
1764
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Triplet Combination of Endocrine Therapy with CDK 4/6 Inhibitor, Ribociclib, and MTOR Inhibitor, Everolimus in HR+, HER2-ABC: Results from the Dose-Expansion Cohort. (November 2017)

Authors:
Bardia, Aditya; Cortés, Javier; Modi, Shanu; Oliveira, Mafalda; Campone, Mario; Ma, Brigette; Dirix, Luc; Weise, Amy; Kittaneh, Muaiad; Hewes, Becker; Wang, Yingbo; Stegert, Mario; Elmeliegy, Mohamed; Liu, Xiaochun; Chavez-Macgregor, Mariana
Journal:
Breast
Issue:
Volume 36(2017)
Page Start:
S46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search